OR WAIT null SECS
Susan Haigney is lead editor of BioPharm International®.
April 12, 2022
Pharmaceutical Technology asked Jeff Elton, PhD, CEO of ConcertAI, about the role technology plays in performing CAPAs.
April 02, 2022
Performing corrective action and preventive action (CAPA) activities is often necessary to investigate a manufacturing deviation and prevent it from reoccurring. Pharmaceutical Technology asked Joe O’Gorman, head of Global Operations at LZ Lifescience, a Cognizant Company, about the role technology plays in performing CAPAs.
The booming cell therapy market has created a need for capacity that outsourcing partners are ready to fill.
March 15, 2022
Disruptions in the bio/pharmaceutical supply chain can have serious impacts on the quality and availability of life-saving medicines.
February 01, 2022
CDMOs offer expertise and customization options for sponsors of orphan drugs.
January 02, 2022
As regulators balance pandemic tasks and rethink procedures, quality at manufacturing facilities is still a priority.